)
)
Aptahem Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Aptahem
Access all reports
Aptahem specializes in the research and development of therapeutic drugs aimed at treating severe and life-threatening conditions. The company focuses on innovative treatments for diseases related to inflammation and coagulation disorders. Aptahem utilizes proprietary aptamer-based technology to develop its pharmaceutical candidates. The company is headquartered in Malmö, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
APTA
Country
🇸🇪 Sweden